| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive Director
1 company
Megan Boston is Executive Director at BNTC. Megan Boston's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $218K at current prices.
Net of sales, the BNTC filings show accumulation of 25,907 shares.
Megan Boston has 6 Form 4 filings on record from December 2020 to November 2025, all as Chief Financial Officer at Benitec Biopharma (BNTC), 2020–2025.
The 7 reported transactions were 5 option or other derivative awards and 2 open-market purchases.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2023 | BNTC Benitec Biopharma Inc. | Executive Director | Buy | 25,907 | $0.00 | - | New | +27.8% | +217.8% |